Perfusion bioreactors culture cells over much longer periods, even months, by continuously feeding the cells with fresh media and removing spent media while keeping cells in culture. In perfusion there are different ways to keep the cells in culture while removing spent media.
The first kind need to mention is Mid-Scale (100Liters to 1,000 Liters), it hold a comparatively larger share in global market, which accounts for about 45.22% in 2018.

Market Analysis and Insights: Global Perfusion Bioreactor Market
The global Perfusion Bioreactor market is valued at US$ 639.7 million in 2019. The market size will reach US$ 1200.2 million by the end of 2026, growing at a CAGR of 9.3% during 2021-2026.

Global Perfusion Bioreactor Scope and Market Size
Perfusion Bioreactor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Perfusion Bioreactor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Small Scale (≤100 Liters)
Mid-Scale (100 Liters to 1,000 Liters)
Large Scale (>1,000 Liters)

Segment by Application
Biopharmaceutical
Biotechnology
Others

By Company
Sartorius AG
Thermo Fisher
GE Healthcare Life Sciences
Pall
Eppendorf AG
ZETA
3D Biotek
Infors HT
Applikon Biotechnology
Bioengineering AG
PBS Biotech, Inc.
Cell Culture Company
Zellwerk GmbH

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia